Works matching IS 09509232 AND DT 2015 AND VI 34 AND IP 6

Results: 13

TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells.
Published in:
Oncogene, 2015, v. 34, n. 6, p. 681, doi. 10.1038/onc.2014.5
By:
- Bartucci, M;
- Dattilo, R;
- Moriconi, C;
- Pagliuca, A;
- Mottolese, M;
- Federici, G;
- Benedetto, A Di;
- Todaro, M;
- Stassi, G;
- Sperati, F;
- Amabile, M I;
- Pilozzi, E;
- Patrizii, M;
- Biffoni, M;
- Maugeri-Saccà, M;
- Piccolo, S;
- De Maria, R
Publication type:
Article
SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model.
Published in:
Oncogene, 2015, v. 34, n. 6, p. 671, doi. 10.1038/onc.2014.4
By:
- Kim, G;
- Ouzounova, M;
- Quraishi, A A;
- Davis, A;
- Tawakkol, N;
- Clouthier, S G;
- Malik, F;
- Paulson, A K;
- D'Angelo, R C;
- Korkaya, S;
- Baker, T L;
- Esen, E S;
- Prat, A;
- Liu, S;
- Kleer, C G;
- Thomas, D G;
- Wicha, M S;
- Korkaya, H
Publication type:
Article
Regulation of the mitogen-activated protein kinase kinase (MEK)-1 by NAD<sup>+</sup>-dependent deacetylases.
Published in:
Oncogene, 2015, v. 34, n. 6, p. 798, doi. 10.1038/onc.2014.39
By:
- Yeung, F;
- Ramsey, C S;
- Popko-Scibor, A E;
- Allison, D F;
- Gray, L G;
- Shin, M;
- Kumar, M;
- Li, D;
- McCubrey, J A;
- Mayo, M W
Publication type:
Article
The von Hippel-Lindau tumor suppressor regulates programmed cell death 5-mediated degradation of Mdm2.
Published in:
Oncogene, 2015, v. 34, n. 6, p. 771, doi. 10.1038/onc.2013.598
By:
- Essers, P B;
- Klasson, T D;
- Pereboom, T C;
- Mans, D A;
- Nicastro, M;
- Boldt, K;
- Giles, R H;
- MacInnes, A W
Publication type:
Article
The TrkB+ cancer stem cells contribute to post-chemotherapy recurrence of triple-negative breast cancers in an orthotopic mouse model.
Published in:
Oncogene, 2015, v. 34, n. 6, p. 761, doi. 10.1038/onc.2014.8
By:
- Yin, B;
- Ma, Z Y;
- Zhou, Z W;
- Gao, W C;
- Du, Z G;
- Zhao, Z H;
- Li, Q Q
Publication type:
Article
PRC2-independent chromatin compaction and transcriptional repression in cancer.
Published in:
Oncogene, 2015, v. 34, n. 6, p. 741, doi. 10.1038/onc.2013.604
By:
- Vallot, C;
- Hérault, A;
- Boyle, S;
- Bickmore, W A;
- Radvanyi, F
Publication type:
Article
miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer.
Published in:
Oncogene, 2015, v. 34, n. 6, p. 717, doi. 10.1038/onc.2014.9
By:
- Wen, S-Y;
- Lin, Y;
- Yu, Y-Q;
- Cao, S-J;
- Zhang, R;
- Yang, X-M;
- Li, J;
- Zhang, Y-L;
- Wang, Y-H;
- Ma, M-Z;
- Sun, W-W;
- Lou, X-L;
- Wang, J-H;
- Teng, Y-C;
- Zhang, Z-G
Publication type:
Article
E-Cadherin and EpCAM expression by NSCLC tumour cells associate with normal fibroblast activation through a pathway initiated by integrin αvβ6 and maintained through TGFβ signalling.
Published in:
Oncogene, 2015, v. 34, n. 6, p. 704, doi. 10.1038/onc.2013.600
By:
- Eberlein, C;
- Rooney, C;
- Ross, S J;
- Farren, M;
- Weir, H M;
- Barry, S T
Publication type:
Article
Juvenile myelomonocytic leukaemia-associated mutation in Cbl promotes resistance to apoptosis via the Lyn-PI3K/AKT pathway.
Published in:
Oncogene, 2015, v. 34, n. 6, p. 789, doi. 10.1038/onc.2013.596
By:
- Bunda, S;
- Qin, K;
- Kommaraju, K;
- Heir, P;
- Ohh, M
Publication type:
Article
Selective killing of lung cancer cells by miRNA-506 molecule through inhibiting NF-κB p65 to evoke reactive oxygen species generation and p53 activation.
Published in:
Oncogene, 2015, v. 34, n. 6, p. 691, doi. 10.1038/onc.2013.597
By:
- Yin, M;
- Ren, X;
- Zhang, X;
- Luo, Y;
- Wang, G;
- Huang, K;
- Feng, S;
- Bao, X;
- He, X;
- Liang, P;
- Wang, Z;
- Tang, H;
- He, J;
- Zhang, B
Publication type:
Article
Modification of sialylation is associated with multidrug resistance in human acute myeloid leukemia.
Published in:
Oncogene, 2015, v. 34, n. 6, p. 726, doi. 10.1038/onc.2014.7
By:
- Ma, H;
- Zhou, H;
- Song, X;
- Shi, S;
- Zhang, J;
- Jia, L
Publication type:
Article
miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer.
Published in:
Oncogene, 2015, v. 34, n. 6, p. 780, doi. 10.1038/onc.2014.11
By:
- Lahdaoui, F;
- Delpu, Y;
- Vincent, A;
- Renaud, F;
- Messager, M;
- Duchêne, B;
- Leteurtre, E;
- Mariette, C;
- Torrisani, J;
- Jonckheere, N;
- Van Seuningen, I
Publication type:
Article
The stem cell transcription factor ZFP57 induces IGF2 expression to promote anchorage-independent growth in cancer cells.
Published in:
Oncogene, 2015, v. 34, n. 6, p. 752, doi. 10.1038/onc.2013.599
By:
- Tada, Y;
- Yamaguchi, Y;
- Kinjo, T;
- Song, X;
- Akagi, T;
- Takamura, H;
- Ohta, T;
- Yokota, T;
- Koide, H
Publication type:
Article